SurModics
$38.369876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$38.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.57 (-1.46%) Today
$0.00 (0.00%) As of 1:11 PM EST after-hours
Why Robinhood?
You can buy or sell SurModics and other stocks, options, and ETFs commission-free!
About SRDX
SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN. The listed name for SRDX is Surmodics, Inc. Common Stock.
CEO
Gary R. Maharaj
Employees
369
Headquarters
Eden Prairie, Minnesota
Founded
1979
Market Cap
523.43M
Price-Earnings Ratio
479.50
Dividend Yield
—
Average Volume
40.45K
High Today
$39.01
Low Today
$37.66
Open Price
$38.93
Volume
23.96K
52 Week High
$49.00
52 Week Low
$22.06
Collections
SRDX Earnings
-$0.18
$0.00
$0.19
$0.37
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Feb 3, After Hours